Toho, for the fiscal year ending February 2025, operating profit increased by 9.2% to 64.6 billion yen, while Financial Estimates for February 2026 are projected to decrease by 11.9% to 57 billion yen.
Toho <9602> announced its financial results for the fiscal year ending February 2025, with operating revenue increasing by 10.5% compared to the previous period to 313.171 billion yen, and operating profit rising by 9.2% to 64.684 billion yen. For the fiscal year ending February 2026, the company plans operating revenue to decrease by 4.2% to 300 billion yen and operating profit to decrease by 11.9% to 57 billion yen. Additionally, the income from the distribution rights of the blockbuster movie "Godzilla -1.0" will drop, and the temporary closure of the Imperial Theatre due to reconstruction work will have an impact. This represents 5.63% of the total number of outstanding Stocks.
PostPrime: Presentation of financial results for the 3rd quarter of the fiscal year ending May 2025
PostPrime: Summary of Financial Results for the 3rd Quarter Ending May 2025 [Japanese GAAP] (Consolidated)
Cosmos Pharmaceutical, Asterisk, Asahi Chemicals, Takashimaya (14th)
※ The above Calendar is merely a schedule and is subject to change due to the company's circumstances.--------------------------------------- April 14 (Monday) <135A> VRAIN <138A> Hikari Food Service <1407> West HD <1418> Interlife <1430> 1st Corp <1434> JESCO HD <156A> Material G <
Toho's operating profit in the third quarter increased by 26.9% to 52.8 billion yen.
Toho <9602> announced that for the third quarter of the fiscal period ending February 2025, operating revenue increased by 15.3% year-on-year to 234.169 billion yen, and operating profit rose by 26.9% to 52.81 billion yen. The film exhibition business saw a decrease in both revenue and profit compared to the previous year, but the sales of character goods related to Toho's monster characters, centered around 'Godzilla,' significantly contributed to operating income. 【Positive evaluation】 <3266> FundクリG full year | <9837> Morito full year <4413> Board
PostPrime: Half Year Report - Term 6 (2024/06/01 - 2025/05/31)
PostPrime: Notice regarding consolidated earnings forecasts associated with the commencement of consolidated financial results
PostPrime: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending May 2025 [Japanese GAAP] (consolidated)
PostPrime: Presentation of financial results for the 2nd quarter of the fiscal year ending May 2025
Kasumigaseki Capital, Asahi Chemicals, Toho, Bunkyo HD (14th)
※ The above Calendar is merely a schedule and may be subject to change due to corporate circumstances. --------------------------------------- January 14 (Tuesday) <135A> VRAIN <1377> Sakata Seed <138A> Hikari Food Service <1401> mbs <1407> West HD <1418> Interlife <1419> Tama Home <1430> 1st Co.
WOLVES HAND, Towns, PostPrime.
■WOLVES HAND <194A> Estimated number of shares to be released: 6,468,400 shares (estimated) Release date: 2024/12/17 If, after the listing date, the stock price exceeds 1.5 times the public offering price, there may have been a possibility of sale. Target shareholders: Estimated shares J-STAR No.3 SS, LP: 1,232,298 shares J-STAR No.3 JF, LP: 638,389 shares J-STAR No.3 JC, LP: 527,951 shares J-STAR No.3 GF,
Volume change rate ranking (9 o'clock)~ Logos HD, Base Food, etc. ranked in.
In the volume change rate ranking, by comparing the average volume of the last 5 days with the volume on the day of distribution, you can understand the interests of market participants such as trends in trading. ■ Volume Change Rate Top [As of 9:32 on October 16] (Comparison of the average volume of the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <1486> Listed US Bonds 5127 1071 85.08% 0.0008% <4570> Immunobiology 8
Toho, upward revision on 2/25, operating profit of 620 billion yen←55 billion.
Toho <9602> announced a revision of the financial estimates for the fiscal year ending February 2025. Operating revenue has been revised upward from 280 billion yen to 297 billion yen, and operating profit from 55 billion yen to 62 billion yen. In the main movie business, hits such as "Strange Family," "Detective Conan: The Five-Star Stories with a Million Dollar Tag," "Kingdom: The Return of the General," and "The Last Mile" have contributed, along with the unexpected success of the sequel from the previous consolidated fiscal year, "Haikyu!! Movie: The Battle of the Trash Dump," exceeding box office revenue expectations at over 11.5 billion yen. Additionally,
PostPrime: Summary of financial results for the 1st quarter of the fiscal year ending May 2025 [Japanese GAAP] (unconsolidated)
PostPrime: Presentation of financial results for the 1st quarter of the fiscal year ending May 2025
TKP, Hio Den, Takashimaya, Toho (15th)
※The above calendar is subject to change due to company's convenience. ---------------------------------------October 15th (Tuesday) <135A> VRAIN <1401> mbs <1407> West HD <1418> Interlife <1430> 1st Corp <1434> JESCOHD <1887> Japan Land Development <198A>
DELTA-P, Rena Science, and others.
<198A> Established a post-main board subsidiary <4598> DELTA-PDF-10917 and VEN has started registration of clinical phase 1/2 trials (USA) <4889> RENASCENCE National Institute of Biomedical Innovation, Health and Nutrition (AMED) The adoption of the Smart Bio Drug Discovery Research Support Project <7050> Acquired and subsidiaryized the stock of Cinébridge, engaged in Frontier i advertising business
PostPrime: Interim report
PostPrime: Confirmation letter
PostPrime: Securities Report - 5th Term (2023/06/01-2024/05/31)